• OPEN AN ACCOUNT
Indian Indices
Nifty
25,722.10 -155.75
(-0.60%)
Sensex
83,938.71 -465.75
( -0.55%)
Bank Nifty
57,776.35 -254.75
( -0.44%)
Nifty IT
35,712.35 -194.05
( -0.54%)
Global Indices
Nasdaq
47,580.95 37.83
(0.08%)
Dow Jones
6,861.23 17.89
(0.26%)
Hang Seng
52,282.77 957.16
(1.86%)
Nikkei 225
9,715.58 -44.48
(-0.46%)
Forex
USD-INR
88.57 0.35
(0.39%)
EUR-INR
102.67 0.05
(0.05%)
GBP-INR
116.69 0.04
(0.03%)
JPY-INR
0.58 0.00
(-0.51%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
16.5329749
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
165.31
36.9
EPS(TTM)
Face Value()
Div & Yield %
0.16
10
0
 

Ultracab (India) standalone net profit rises 35.03% in the March 2025 quarter
May 29,2025
Net profit of Ultracab (India) rose 35.03% to Rs 2.39 crore in the quarter ended March 2025 as against Rs 1.77 crore during the previous quarter ended March 2024. Sales rose 63.71% to Rs 72.95 crore in the quarter ended March 2025 as against Rs 44.56 crore during the previous quarter ended March 2024.

For the full year,net profit rose 62.54% to Rs 9.72 crore in the year ended March 2025 as against Rs 5.98 crore during the previous year ended March 2024. Sales rose 93.00% to Rs 239.43 crore in the year ended March 2025 as against Rs 124.06 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales72.9544.56 64 239.43124.06 93
OPM %6.859.85 -8.1210.55 -
PBDT3.993.24 23 14.949.41 59
PBT3.673.01 22 13.748.54 61
NP2.391.77 35 9.725.98 63